In drug discrimination (DD) procedures, behavior is differentially reinforced depending on
the presence or absence of specific drug stimuli. The DD paradigm has been widely adopted …

This study evaluated the efficacy of a combination tablet formulation of buprenorphine
containing 8 mg of buprenorphine and 2 mg of naloxone for every other day treatment and …

Abstract Effects of the dopamine D 1 antagonist SCH 39166 were compared with those of
the D 2 antagonist eticlopride in squirrel monkeys responding under a second-order fixed-…

Homeless men who have sex with men are a particularly vulnerable population with high
rates of substance dependence, psychiatric disorders, and HIV prevalence. Most need strong …

The discriminative stimulus (DS) effects of smoked marijuana were studied by training marijuana
smokers to discriminate between the effects of marijuana containing 2.7% △ 9 -THC (M…

A sublingual tablet formulation of buprenorphine combining 8 mg of buprenorphine with 2
mg of naloxone is being targeted for use in settings where less than daily dosing strategies …

This is the first randomised study comparing buprenorphine-naloxone with methadone for
maintenance treatment of opioid dependence. A 17-week, double-blind, double-dummy trial of …

Reviews recent studies, conducted mainly with nonhuman primates, concerning the role of
D₁ and D₂ receptors in the behavioral effects of cocaine. The extent to which selective …

Office-based buprenorphine-naloxone (Suboxone) treatment in the United States has
significantly improved access to safe and effective opioid-dependence therapy. Little data from …

During January and February 2003, 20 non-treatment seeking homeless, substance-using
MSM accessing community-based prevention services in West Hollywood, California were …